Shares of AbbVie dropped 3.3% to $105.21 at 10:37 EST on Wednesday, after three successive sessions in a row of losses. NYSE Composite is dropping 0.45% to $14,867.37, after four successive sessions in a row of losses. This seems, up until now, a somewhat rough trend exchanging session today.
AbbVie’s last close was $110.50, 7.79% under its 52-week high of $113.41.
AbbVie’s Sales
AbbVie’s sales growth is 57.5% for the present quarter and 50.4% for the next. The company’s growth estimates for the ongoing quarter and the next is 29% and 14%, respectively.
AbbVie’s Revenue
Year-on-year quarterly revenue growth grew by 52.2%, now sitting on 40.65B for the twelve trailing months.
Volatility
AbbVie’s last day, last week, and last month’s average volatility was a negative 0.33%, a negative 0.00%, and a positive 0.35%, respectively.
AbbVie’s last day, last week, and last month’s high and low average amplitude percentage was 1.85%, 1.78%, and 1.92%, respectively.
AbbVie’s Stock Yearly Top and Bottom Value
AbbVie’s stock is valued at $105.21 at 10:37 EST, below its 52-week high of $113.41 and way higher than its 52-week low of $62.55.
AbbVie’s Moving Average
AbbVie’s worth is under its 50-day moving average of $107.06 and higher than its 200-day moving average of $96.53.
